{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T05:33:10Z","timestamp":1794893590953,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7937","license":[{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2022,11,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The tumour-associated microbiota is an intrinsic component of the tumour microenvironment across human cancer types\n                    <jats:sup>1,2<\/jats:sup>\n                    . Intratumoral host\u2013microbiota studies have so far largely relied on bulk tissue analysis\n                    <jats:sup>1\u20133<\/jats:sup>\n                    , which obscures the spatial distribution and localized effect of the microbiota within tumours. Here, by applying in situ spatial-profiling technologies\n                    <jats:sup>4<\/jats:sup>\n                    and single-cell RNA sequencing\n                    <jats:sup>5<\/jats:sup>\n                    to oral squamous cell carcinoma and colorectal cancer, we reveal spatial, cellular and molecular host\u2013microbe interactions. We adapted 10x Visium spatial transcriptomics to determine the identity and in situ location of intratumoral microbial communities within patient tissues. Using GeoMx digital spatial profiling\n                    <jats:sup>6<\/jats:sup>\n                    , we show that bacterial communities populate microniches that are less vascularized, highly immuno\u2011suppressive and associated with malignant cells with lower levels of Ki-67\u00a0as compared to bacteria-negative tumour regions. We developed a single-cell RNA-sequencing method that we name INVADEseq (invasion\u2013adhesion-directed expression sequencing) and, by applying this to patient tumours, identify cell-associated bacteria and the host cells with which they interact, as well as uncovering alterations in transcriptional pathways that are involved in inflammation, metastasis, cell dormancy and DNA repair. Through functional studies, we show that cancer cells that are infected with bacteria invade their surrounding environment as single cells and recruit myeloid cells to bacterial regions. Collectively, our data reveal that the distribution of the microbiota within a tumour is not random; instead, it is highly organized in microniches with immune and epithelial cell functions that promote cancer progression.\n                  <\/jats:p>","DOI":"10.1038\/s41586-022-05435-0","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T12:05:04Z","timestamp":1668600304000},"page":"810-817","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":894,"title":["Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer"],"prefix":"10.1038","volume":"611","author":[{"given":"Jorge Luis","family":"Galeano Ni\u00f1o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanrui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn D.","family":"LaCourse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4984-9684","authenticated-orcid":false,"given":"Andrew G.","family":"Kempchinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Baryiames","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Barber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal","family":"Futran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Houlton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassie","family":"Sather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Sicinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1639-3905","authenticated-orcid":false,"given":"Samuel S.","family":"Minot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6765-2383","authenticated-orcid":false,"given":"Christopher D.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7713-0810","authenticated-orcid":false,"given":"Susan","family":"Bullman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,16]]},"reference":[{"key":"5435_CR1","doi-asserted-by":"publisher","first-page":"eabc4552","DOI":"10.1126\/science.abc4552","volume":"371","author":"GD Sepich-Poore","year":"2021","unstructured":"Sepich-Poore, G. D. et al. The microbiome and human cancer. Science 371, eabc4552 (2021).","journal-title":"Science"},{"key":"5435_CR2","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.aay9189","volume":"368","author":"D Nejman","year":"2020","unstructured":"Nejman, D. et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science 368, 973\u2013980 (2020).","journal-title":"Science"},{"key":"5435_CR3","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1101\/gr.126573.111","volume":"22","author":"AD Kostic","year":"2012","unstructured":"Kostic, A. D. et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 22, 292\u2013298 (2012).","journal-title":"Genome Res"},{"key":"5435_CR4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41586-021-03634-9","volume":"596","author":"A Rao","year":"2021","unstructured":"Rao, A., Barkley, D., Franca, G. S. & Yanai, I. Exploring tissue architecture using spatial transcriptomics. Nature 596, 211\u2013220 (2021).","journal-title":"Nature"},{"key":"5435_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/nmeth.1315","volume":"6","author":"F Tang","year":"2009","unstructured":"Tang, F. et al. mRNA-seq whole-transcriptome analysis of a single cell. Nat. Methods 6, 377\u2013382 (2009).","journal-title":"Nat. Methods"},{"key":"5435_CR6","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41587-020-0472-9","volume":"38","author":"CR Merritt","year":"2020","unstructured":"Merritt, C. R. et al. Multiplex digital spatial profiling of proteins and RNA in fixed tissue. Nat. Biotechnol. 38, 586\u2013599 (2020).","journal-title":"Nat. Biotechnol."},{"key":"5435_CR7","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S2468-1253(20)30362-9","volume":"6","author":"KD LaCourse","year":"2021","unstructured":"LaCourse, K. D., Johnston, C. D. & Bullman, S. The relationship between gastrointestinal cancers and the microbiota. Lancet Gastroenterol. Hepatol. 6, 498\u2013509 (2021).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"5435_CR8","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1126\/science.aal5240","volume":"358","author":"S Bullman","year":"2017","unstructured":"Bullman, S. et al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science 358, 1443\u20131448 (2017).","journal-title":"Science"},{"key":"5435_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16967-2","volume":"11","author":"L Parhi","year":"2020","unstructured":"Parhi, L. et al. Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression. Nat. Commun. 11, 3259 (2020).","journal-title":"Nat. Commun."},{"key":"5435_CR10","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.cell.2022.02.027","volume":"185","author":"A Fu","year":"2022","unstructured":"Fu, A. et al. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer. Cell 185, 1356\u20131372 (2022).","journal-title":"Cell"},{"key":"5435_CR11","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.12.040","volume":"176","author":"C Jin","year":"2019","unstructured":"Jin, C. et al. Commensal microbiota promote lung cancer development via \u03b3\u03b4 T cells. Cell 176, 998\u20131013 (2019).","journal-title":"Cell"},{"key":"5435_CR12","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","volume":"178","author":"E Riquelme","year":"2019","unstructured":"Riquelme, E. et al. Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Cell 178, 795\u2013806 (2019).","journal-title":"Cell"},{"key":"5435_CR13","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41586-021-03368-8","volume":"592","author":"S Kalaora","year":"2021","unstructured":"Kalaora, S. et al. Identification of bacteria-derived HLA-bound peptides in melanoma. Nature 592, 138\u2013143 (2021).","journal-title":"Nature"},{"key":"5435_CR14","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.cell.2017.07.008","volume":"170","author":"T Yu","year":"2017","unstructured":"Yu, T. et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell 170, 548\u2013563 (2017).","journal-title":"Cell"},{"key":"5435_CR15","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aah5043","volume":"357","author":"LT Geller","year":"2017","unstructured":"Geller, L. T. et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science 357, 1156\u20131160 (2017).","journal-title":"Science"},{"key":"5435_CR16","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41586-020-2095-1","volume":"579","author":"GD Poore","year":"2020","unstructured":"Poore, G. D. et al. Microbiome analyses of blood and tissues suggest cancer diagnostic approach. Nature 579, 567\u2013574 (2020).","journal-title":"Nature"},{"key":"5435_CR17","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1093\/bioinformatics\/bty501","volume":"34","author":"MA Walker","year":"2018","unstructured":"Walker, M. A. et al. GATK PathSeq: a customizable computational tool for the discovery and identification of microbial sequences in libraries from eukaryotic hosts. Bioinformatics 34, 4287\u20134289 (2018).","journal-title":"Bioinformatics"},{"key":"5435_CR18","doi-asserted-by":"publisher","first-page":"4871","DOI":"10.1182\/blood-2009-05-220806","volume":"114","author":"JA Van Ziffle","year":"2009","unstructured":"Van Ziffle, J. A. & Lowell, C. A. Neutrophil-specific deletion of Syk kinase results in reduced host defense to bacterial infection. Blood 114, 4871\u20134882 (2009).","journal-title":"Blood"},{"key":"5435_CR19","doi-asserted-by":"publisher","first-page":"5301","DOI":"10.1158\/0008-5472.CAN-12-4448","volume":"73","author":"R Lara","year":"2013","unstructured":"Lara, R., Seckl, M. J. & Pardo, O. E. The p90 RSK family members: common functions and isoform specificity. Cancer Res. 73, 5301\u20135308 (2013).","journal-title":"Cancer Res."},{"key":"5435_CR20","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1001\/jamaoncol.2015.1377","volume":"1","author":"K Mima","year":"2015","unstructured":"Mima, K. et al. Fusobacterium nucleatum and T cells in colorectal carcinoma. JAMA Oncol. 1, 653\u2013661 (2015).","journal-title":"JAMA Oncol."},{"key":"5435_CR21","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.annonc.2020.06.003","volume":"31","author":"G Serna","year":"2020","unstructured":"Serna, G. et al. Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer. Ann. Oncol. 31, 1366\u20131375 (2020).","journal-title":"Ann. Oncol."},{"key":"5435_CR22","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"I Pastushenko","year":"2019","unstructured":"Pastushenko, I. & Blanpain, C. EMT transition states during tumor progression and metastasis. Trends Cell Biol. 29, 212\u2013226 (2019).","journal-title":"Trends Cell Biol."},{"key":"5435_CR23","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ccr.2014.01.021","volume":"25","author":"PA Muller","year":"2014","unstructured":"Muller, P. A. & Vousden, K. H. Mutant p53 in cancer: new functions and therapeutic opportunities. Cancer Cell 25, 304\u2013317 (2014).","journal-title":"Cancer Cell"},{"key":"5435_CR24","doi-asserted-by":"publisher","first-page":"eabe7729","DOI":"10.1126\/science.abe7729","volume":"372","author":"K Kienle","year":"2021","unstructured":"Kienle, K. et al. Neutrophils self-limit swarming to contain bacterial growth in vivo. Science 372, eabe7729 (2021).","journal-title":"Science"},{"key":"5435_CR25","doi-asserted-by":"publisher","first-page":"6161","DOI":"10.1093\/emboj\/cdg586","volume":"22","author":"MJ Oliveira","year":"2003","unstructured":"Oliveira, M. J. et al. \u03b2-casein-derived peptides, produced by bacteria, stimulate cancer cell invasion and motility. EMBO J. 22, 6161\u20136173 (2003).","journal-title":"EMBO J."},{"key":"5435_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/imammb\/dqq011","volume":"29","author":"H Hatzikirou","year":"2012","unstructured":"Hatzikirou, H., Basanta, D., Simon, M., Schaller, K. & Deutsch, A. \u2018Go or grow\u2019: the key to the emergence of invasion in tumour progression? Math. Med. Biol. 29, 49\u201365 (2012).","journal-title":"Math. Med. Biol."},{"key":"5435_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-39636-x","volume":"9","author":"JA Gallaher","year":"2019","unstructured":"Gallaher, J. A., Brown, J. S. & Anderson, A. R. A. The impact of proliferation\u2013migration tradeoffs on phenotypic evolution in cancer. Sci. Rep. 9, 2425 (2019).","journal-title":"Sci. Rep."},{"key":"5435_CR28","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.cell.2020.08.045","volume":"183","author":"ED Wrenn","year":"2020","unstructured":"Wrenn, E. D. et al. Regulation of collective metastasis by nanolumenal signaling. Cell 183, 395\u2013410 (2020).","journal-title":"Cell"},{"key":"5435_CR29","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","volume":"15","author":"I Dagogo-Jack","year":"2018","unstructured":"Dagogo-Jack, I. & Shaw, A. T. Tumour heterogeneity and resistance to cancer therapies. Nat. Rev. Clin. Oncol. 15, 81\u201394 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"5435_CR30","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1126\/science.1840703","volume":"254","author":"P van der Bruggen","year":"1991","unstructured":"van der Bruggen, P. et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254, 1643\u20131647 (1991).","journal-title":"Science"},{"key":"5435_CR31","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1056\/NEJM198612253152606","volume":"315","author":"HF Dvorak","year":"1986","unstructured":"Dvorak, H. F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315, 1650\u20131659 (1986).","journal-title":"N. Engl. J. Med."},{"key":"5435_CR32","doi-asserted-by":"publisher","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","volume":"30","author":"NM Anderson","year":"2020","unstructured":"Anderson, N. M. & Simon, M. C. The tumor microenvironment. Curr. Biol. 30, R921\u2013R925 (2020).","journal-title":"Curr. Biol."},{"key":"5435_CR33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","volume":"348","author":"JA Joyce","year":"2015","unstructured":"Joyce, J. A. & Fearon, D. T. T cell exclusion, immune privilege, and the tumor microenvironment. Science 348, 74\u201380 (2015).","journal-title":"Science"},{"key":"5435_CR34","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1158\/2159-8290.CD-19-1384","volume":"10","author":"Y Kieffer","year":"2020","unstructured":"Kieffer, Y. et al. Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer. Cancer Discov. 10, 1330\u20131351 (2020).","journal-title":"Cancer Discov."},{"key":"5435_CR35","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41422-020-0355-0","volume":"30","author":"J Qian","year":"2020","unstructured":"Qian, J. et al. A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling. Cell Res. 30, 745\u2013762 (2020).","journal-title":"Cell Res."},{"key":"5435_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22801-0","volume":"12","author":"F Wu","year":"2021","unstructured":"Wu, F. et al. Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer. Nat. Commun. 12, 2540 (2021).","journal-title":"Nat. Commun."},{"key":"5435_CR37","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1126\/science.abf8403","volume":"374","author":"N Pernigoni","year":"2021","unstructured":"Pernigoni, N. et al. Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis. Science 374, 216\u2013224 (2021).","journal-title":"Science"},{"key":"5435_CR38","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/s41592-019-0548-y","volume":"16","author":"S Vickovic","year":"2019","unstructured":"Vickovic, S. et al. High-definition spatial transcriptomics for in situ tissue profiling. Nat. Methods 16, 987\u2013990 (2019).","journal-title":"Nat. Methods"},{"key":"5435_CR39","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.cell.2015.05.002","volume":"161","author":"EZ Macosko","year":"2015","unstructured":"Macosko, E. Z. et al. Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Cell 161, 1202\u20131214 (2015).","journal-title":"Cell"},{"key":"5435_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26614-z","volume":"12","author":"MV Hunter","year":"2021","unstructured":"Hunter, M. V., Moncada, R., Weiss, J. M., Yanai, I. & White, R. M. Spatially resolved transcriptomics reveals the architecture of the tumor-microenvironment interface. Nat. Commun. 12, 6278 (2021).","journal-title":"Nat. Commun."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-05435-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-05435-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-05435-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T07:02:59Z","timestamp":1696316579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-05435-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,16]]},"references-count":40,"journal-issue":{"issue":"7937","published-print":{"date-parts":[[2022,11,24]]}},"alternative-id":["5435"],"URL":"https:\/\/doi.org\/10.1038\/s41586-022-05435-0","relation":{"is-basis-for":[{"id-type":"doi","id":"10.52843\/cassyni.0vd8kj","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,16]]},"assertion":[{"value":"9 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.B. has consulted for GlaxoSmithKline and BiomX. C.D.J. has consulted for Series Therapeutics and Azitra. S.B. is an inventor on US patent application no. PCT\/US2018\/042966, submitted by the Broad Institute and Dana-Farber Cancer Institute, which covers the targeting of\u00a0<i>Fusobacterium<\/i>\u00a0for the treatment of colorectal cancer. K.D.L. is currently employed by NanoString Technologies.\u00a0The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}